Table 3.
The association between GST genotypes and hematological parameters in the study population
| Blood parameters | GSTP1 | GSTT1 | GSTM1 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| AA n = 143 | AG + GG n = 165 | MD% | Positive n = 234 | Null n = 74 | MD % | Positive n = 156 | Null n = 152 | MD% | |
| WBC | 7.013 ± 1.75 | 7.057 ± 1.75 | 0.62% | 7.028 ± 1.69 | 7.062 ± 1.62 | 0.48% | 6.808 ± 1.54a | 7.270 ± 1.77 | 6.78% |
| RBC | 4.98 ± 0.196 | 5.028 ± 0.48 | 0.96% | 4.99 ± 0.452 | 5.06 ± 0.508 | 1.4% | 4.97 ± 0.42 | 5.043 ± 0.503 | 1.46% |
| HB | 15.00 ± 1.19 | 15.12 ± 1.24 | 0.8% | 15.068 ± 1.18 | 15.081 ± 1.33 | 0.08% | 15.055 ± 1.25 | 15.087 ± 1.17 | 0.21% |
| HCT | 43.86 ± 3.28 | 43.80 ± 2.65 | 0.13% | 43.732 ± 3.03 | 44.164 ± 2.67 | 0.98% | 43.735 ± 3.23 | 43.938 ± 2.65 | 0.46% |
| MCV | 87.61 ± 7.93 | 87.67 ± 6.5 | 0.068% | 87.858 ± 6.14 | 86.964 ± 9.83 | 1.02% | 87.710 ± 7.44 | 87.576 ± 6.94 | 0.15% |
| MCH | 30.38 ± 2.76 | 30.26 ± 3.05 | 0.39% | 30.419 ± 2.69 | 30.015 ± 3.52 | 1.34% | 30.434 ± 2.53 | 30.207 ± 3.26 | 0.75% |
| MCHC | 34.38 ± 1.29 | 34.82 ± 4.29 | 1.27% | 34.765 ± 3.62 | 34.142 ± 1.58 | 1.82% | 34.442 ± 1.28 | 34.793 ± 4.45 | 1.02% |
| RDW | 12.20 ± 0.60 | 12.22 ± 0.76 | 0.16% | 12.222 ± 0.72 | 12.200 ± 0.60 | 0.18% | 12.230 ± 0.78 | 12.203 ± 0.59 | 0.22% |
| PLT | 206.35 ± 39.7 | 209.96 ± 42.07 | 1.74% | 211.85 ± 40.5 | 196.94 ± 40.452a | 7.57% | 205.83 ± 36.8 | 210.78 ± 44.7 | 2.4% |
| LY | 41.41 ± 9.7 | 40.72 ± 8.35 | 1.69% | 40.698 ± 8.75 | 42.156 ± 9.87 | 3.58% | 41.278 ± 8.54 | 40.812 ± 9.5 | 1.14% |
| MO | 2.9 ± 1.6 | 3.05 ± 1.7 | 5.17 | 2.978 ± 1.63 | 3.021 ± 1.85 | 1.44% | 3.119 ± 1.75 | 2.855 ± 1.6 | 9.24% |
| GR | 54.75 ± 10.1 | 55.32 ± 8.8 | 1.04% | 55.328 ± 9.22 | 54.215 ± 10.08 | 2.05% | 54.458 ± 9.15 | 55.677 ± 9.69 | 2.24% |
MD mean differences between two groups %
aSignificantly different (independent sample t test, p < 0.05)